Unibios Holdings S.A. (ATH: BIOSK)
Greece
· Delayed Price · Currency is EUR
1.380
+0.015 (1.10%)
Nov 20, 2024, 10:44 AM EET
Unibios Holdings Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 13.59 | 12.98 | 11.24 | 8.48 | 7.3 | 8.34 | Upgrade
|
Revenue Growth (YoY) | 5.30% | 15.41% | 32.63% | 16.14% | -12.47% | 3.91% | Upgrade
|
Cost of Revenue | 8.29 | 8.09 | 7.05 | 5.36 | 4.6 | 4.9 | Upgrade
|
Gross Profit | 5.31 | 4.89 | 4.19 | 3.12 | 2.7 | 3.44 | Upgrade
|
Selling, General & Admin | 3.22 | 3.05 | 2.95 | 2.51 | 2.39 | 2.53 | Upgrade
|
Research & Development | 0.1 | 0.1 | - | - | - | - | Upgrade
|
Other Operating Expenses | -0.08 | -0.07 | -0.09 | -0.12 | -0.11 | 0.18 | Upgrade
|
Operating Expenses | 3.38 | 3.21 | 2.86 | 2.39 | 2.28 | 2.71 | Upgrade
|
Operating Income | 1.93 | 1.68 | 1.34 | 0.72 | 0.42 | 0.72 | Upgrade
|
Interest Expense | -0.42 | -0.62 | -0.39 | -0.37 | -0.39 | -0.45 | Upgrade
|
Interest & Investment Income | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Currency Exchange Gain (Loss) | -0.03 | -0.02 | -0.04 | 0 | -0.01 | -0.03 | Upgrade
|
Other Non Operating Income (Expenses) | -0 | -0 | - | - | - | - | Upgrade
|
EBT Excluding Unusual Items | 1.48 | 1.04 | 0.9 | 0.35 | 0.03 | 0.24 | Upgrade
|
Gain (Loss) on Sale of Investments | -0.42 | - | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 1.33 | 1.33 | 0.03 | 0.02 | 0.01 | 0.01 | Upgrade
|
Other Unusual Items | 0.11 | 0.03 | 0.06 | 0.18 | 0 | 0.05 | Upgrade
|
Pretax Income | 2.5 | 2.4 | 1 | 0.55 | 0.04 | 0.3 | Upgrade
|
Income Tax Expense | 0.5 | 0.37 | 0.35 | 0.22 | 0.13 | 0.2 | Upgrade
|
Earnings From Continuing Operations | 2 | 2.03 | 0.65 | 0.33 | -0.09 | 0.1 | Upgrade
|
Net Income to Company | 2 | 2.03 | 0.65 | 0.33 | -0.09 | 0.1 | Upgrade
|
Net Income | 2 | 2.03 | 0.65 | 0.33 | -0.09 | 0.1 | Upgrade
|
Net Income to Common | 2 | 2.03 | 0.65 | 0.33 | -0.09 | 0.1 | Upgrade
|
Net Income Growth | 176.08% | 211.71% | 94.85% | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 15 | 17 | 16 | 5 | 16 | 7 | Upgrade
|
Shares Outstanding (Diluted) | 15 | 17 | 16 | 5 | 16 | 7 | Upgrade
|
Shares Change (YoY) | -24.19% | 7.80% | 204.21% | -67.87% | 143.98% | 113.97% | Upgrade
|
EPS (Basic) | 0.13 | 0.12 | 0.04 | 0.06 | -0.01 | 0.02 | Upgrade
|
EPS (Diluted) | 0.13 | 0.12 | 0.04 | 0.06 | -0.01 | 0.02 | Upgrade
|
EPS Growth | 264.17% | 189.15% | -35.95% | - | - | - | Upgrade
|
Free Cash Flow | -0.47 | 0.71 | -2.37 | 1.01 | -0.15 | -1.23 | Upgrade
|
Free Cash Flow Per Share | -0.03 | 0.04 | -0.15 | 0.19 | -0.01 | -0.18 | Upgrade
|
Gross Margin | 39.05% | 37.67% | 37.30% | 36.75% | 37.03% | 41.22% | Upgrade
|
Operating Margin | 14.16% | 12.93% | 11.91% | 8.53% | 5.78% | 8.69% | Upgrade
|
Profit Margin | 14.70% | 15.63% | 5.79% | 3.94% | -1.25% | 1.20% | Upgrade
|
Free Cash Flow Margin | -3.48% | 5.48% | -21.06% | 11.92% | -2.04% | -14.75% | Upgrade
|
EBITDA | 2.11 | 1.94 | 1.65 | 0.99 | 0.68 | 1.03 | Upgrade
|
EBITDA Margin | 15.55% | 14.91% | 14.65% | 11.69% | 9.36% | 12.34% | Upgrade
|
D&A For EBITDA | 0.19 | 0.26 | 0.31 | 0.27 | 0.26 | 0.3 | Upgrade
|
EBIT | 1.93 | 1.68 | 1.34 | 0.72 | 0.42 | 0.72 | Upgrade
|
EBIT Margin | 14.16% | 12.93% | 11.91% | 8.53% | 5.78% | 8.69% | Upgrade
|
Effective Tax Rate | 20.01% | 15.58% | 34.79% | 39.47% | 316.44% | 67.04% | Upgrade
|
Advertising Expenses | - | 0.02 | 0.06 | 0.01 | 0.03 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.